2007 Fiscal Year Final Research Report Summary
Role of endothelin-1 and gender difference in the pathogenesis of pulmonary hypertension
| Project/Area Number |
17590232
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
General pharmacology
|
|---|
| Research Institution | Osaka University of Pharmaceutical Sciences |
|---|
Principal Investigator |
MATSUMURA Yasuo Osaka University of Pharmaceutical Sciences, Pharmacology, Professor (40140230)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
TAKAOKA Masanori Osaka University of Pharmaceutical Sciences, Pharmacology, Professor (50140231)
URATA Hidehtio Osaka University of Pharmaceutical Sciences, Pharmacology, Professor (80211085)
|
|---|
| Project Period (FY) |
2005 – 2007
|
| Keywords | endothelin / Pulmonary hypertension / monocrotaline / hypoxia / HIF-1α / raloxifene / gender difference / sex hormone |
|---|
| Research Abstract |
1. Hypoxia (0-1% O_2) increased binding of HIF-la to ET-1_<HIF-1> oligonucleotide. Although hypoxia significantly augmented prepro ET-1 mRNA expression, the ET-1 release from PAECs to the culture medium markedly decreased. The effects of ATP depletion (antimycin A and glucose deprivation) on HIF-la activation and ET-1 production were similar to results seen under hypoxic conditions. On the other hand, hypoxia or ATP depletion increased AMPK phosphorylation. In addition, 5-aminoimidazole-4-carboxamide-1b- riboside (AICAR), which is known as an activator of AMPK, significantly enhanced HIF-1a activation, prepro ET-1 mRNA expression, and AMPK phosphorylation, but markedly decreased the ET-1 release from PAECs. Taken together, these findings suggest that ET-1 production under hypoxic conditions is regulated by not only HIF-1a at a transcriptional level but also AMPK at a translational level.
2. We investigated whether the gender differences in monocrotaline (MCT)-induced pulmonary hypertens
… More
ion (PH) result from the hepatic metabolism of MCT and are related to ET-1 production. Animals given MCT showed severe PH associated with increases in right ventricular pressure and hypertrophy, pulmonary arterial medial thickening, and ET-1 levels in right ventricle. There were no significant differences in MCT-induced alterations between males and females, whereas ovariectomy in females significantly aggravated the above pathologic changes. Thus, we suggest that female hormone have protective functions against the development of MCT-induced PH in females, irrespective of the metabolism of MCT
3. We investigated the effects of chronic treatment with raloxifene on MCT-induced PH in rats. Chronic treatment with raloxifene significantly improved the MCT-induced PH and related organ damage. In addition, chronic treatments with raloxifene significantly suppressed the increment of ET-1 in right ventricle. These results indicate that raloxifene prevents the development of MCT-induced PH and exerts regressive effects on the established PH. Less
|
Research Products
(28 results)
